PTC THERAPEUTICS, INC. — Director's Dealing 2022

Jan 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2022-01-07

Reporting Person: Smith Mary L. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-07	Common Stock	A	3200	—	Acquired	5813	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-07	Stock Option (Right To Buy)	$38.10	A	12000	Acquired	2032-01-06	Common Stock (12000)	Direct

Footnotes

F1: Restricted stock units granted on January 7, 2022 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 8, 2022 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 7, 2023.

F2: This option was granted on January 7, 2022 and vests over one year in twelve equal monthly installments, commencing on February 7, 2022.